Abstract:Oxygen is ubiquitous on the Earth’s surface and essential for the survival of almost all eukaryotes. Nearly all living organisms require molecular oxygen for the metabolism of the macro-molecules to obtain energy for growth, development and reproduction. It is the subject of immense physiological, biochemical and clinical literature. In response to inadequate oxygen availability, eukaryotic body or cells undergo adaptive changes in gene expression program that either enhance oxygen delivery or promote survival in a low oxygen environment. The discovery of the mechanism by which cells sense and adapt to oxygen availability, which is awarded the 2019 Nobel Prize in Physiology or Medicine, lays the foundation for understanding how oxygen affects multiple physiological and pathological process. Hypoxia-inducible factor 1 (HIF-1) lies at the center of the hypoxia signal transduction pathway. HIF-1 was identified in a search for molecules that enhance erythropoietin (EPO) expression in anemia or hypoxia. HIF-1 is a heterodimer composed of α and β subunits, each containing basic helix-loop-helix-PAS (bHLH-PAS) domains. HIF-1β is constitutively expressed, while HIF-1α expression depends on oxygen availability and only a limited amount of protein is stabilized in the cytoplasm. Under hypoxic conditions, expressed cytosolic HIF-1α is stabilized and translocated into the nucleus to form heterodimers with HIF-1β, then binds to hypoxia response elements (HREs) to initiate transcription of target genes. More than 1000 genes have been identified to be directly transcriptionally activated by HIF-1. The proteins encoded by HIF-1 target genes are usually divided into 2 categories: one is those proteins that increase oxygen delivery like EPO, vascular endothelial growth factor (VEGF) et al, and the other is those proteins that decrease oxygen consumption like lactate dehydrogenase A (LDHA), pyruvate dehydrogenase kinase 1 (PDK1) and so on. Under normoxic conditions, prolyl hydroxylase 2 (PHD2), which serves as the sensor of cellular oxygen levels, hydroxylates the conserved proline residues in the α subunit of HIF-1. Hydroxylated HIF-1α is recognized and bound by the ubiquitin ligase von Hippel-Lindau (VHL)/Elongin B/Elongin C/Cullin-2 complex, leading to its rapid degradation by the proteasome. HIF-1α transcription activity is negatively regulated by factor inhibiting HIF-1 (FIH-1) via FIH-1-dependent asparaginyl hydroxylation using oxygen and a-ketoglutarate as substrates, which blocks the association of the coactivators CBP (CREB-binding protein) and p300. Abnormal hypoxia signal transduction contributes to the pathogenesis of many kinds of diseases like hypertension, ocular neovascularization, cancer, erythrocytosis and so on. Currently, extensive efforts are ongoing to develop drugs for clinical treatment of hypoxia-related diseases.

Heritable disorders of oxygen sensing

Hypoxia-inducible factors: roles in cardiovascular disease progression, prevention, and treatment

Hypoxia And Heme Oxygenases: Oxygen Sensing And Regulation Of Expression

Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression

Expression of the Hypoxia-Inducible Factors in the AML and MDS: is Not Associated with the Von Hippel-Lindau Gene

Hypoxia and Heme Oxygenases: Oxygen Sensing and Regulation of Expression.

Oxygen-sensing mechanisms in development and tissue repair

Regulation of Erythropoiesis by the Hypoxia-Inducible Factor Pathway: Effects of Genetic and Pharmacological Perturbations

The Discovery of How Cells Sense and Adapt to Oxygen Availability

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

The Regulatory Mechanism of Hypoxia-inducible Factor 1 and its Clinical Significance

Familial Erythrocytosis Associated with a Mutation in the HIF Prolyl Hydroxylase, PHD2.

Oxygen Sensing by H+: Implications for HIF and Hypoxic Cell Memory

How Cells Sense Oxygen

A Hif1 Alpha Regulatory Loop Links Hypoxia And Mitochondrial Signals In Pheochromocytomas

Oxygen homeostasis and cardiovascular disease: A role for HIF?

Regulation of hypoxia-inducible factor α in inflammation-associated diseases mediated by innate immune cells

Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism

Non-Canonical Mechanisms Regulating Hypoxia-Inducible Factor 1 Alpha in Cancer

Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers

Hypoxia signaling in human health and diseases: implications and prospects for therapeutics